本页面由Tiger Trade Technology Pte. Ltd.提供服务

Assertio Holdings, Inc.

0.7880
+0.00770.99%
盘后0.79030.0023+0.29%19:09 EST
成交量:24.77万
成交额:19.27万
市值:7,584.66万
市盈率:-2.61
高:0.7880
开:0.7505
低:0.7450
收:0.7803
52周最高:1.04
52周最低:0.5137
股本:9,625.21万
流通股本:8,517.00万
量比:0.80
换手率:0.29%
股息:- -
股息率:- -
每股收益(TTM):-0.3018
每股收益(LYR):-0.2265
净资产收益率:-24.48%
总资产收益率:-4.17%
市净率:0.72
市盈率(LYR):-3.48

数据加载中...

公司资料

公司名字:
Assertio Holdings, Inc.
交易所:
NASDAQ
成立时间:
2020
员工人数:
58
公司地址:
100 South Saunders Road,Suite 300,Lake Forest,Illinois,United States
邮编:
60045
电话:
传真:
510 744 8001
简介:
Assertio Holdings, Inc.是一家领先的多元化,商业制药公司,专注于为需要的患者提供增强治疗选择的独特产品。2020年5月19日,Assertio根据合并协议和计划实施了Assertio重组。Assertio Therapeutics是Assertio Holdings的全资子公司。

董事

名称
职位
Mark L. Reisenauer
Director and Chief Executive Officer
Brendan P. O'Grady
Director
David M. Stark
Director
Heather L. Mason
Director
Sigurd C. Kirk
Director
Sravan K. Emany
Director
William T. McKee
Director

股东

名称
职位
Mark L. Reisenauer
Director and Chief Executive Officer
Paul Schwichtenberg
President and Chief Operating Officer
Ajay Patel
Executive Vice President and Chief Financial Officer
Mary E. Pietryga
Executive Vice President and Chief Commercial Officer
Sam Schlessinger
Executive Vice President and General Counsel